Evidence map›Paper›PMID 40635330›Full record

ReviewJournal of clinical and experimental neuropsychology2025

Neuropsychological function in childhood cancer patients and adult survivors of childhood cancer.

Lisa M Jacola, Rachel K Peterson, Kaitlin A Oswald-McCloskey, Angela Sekely, Donald J Mabbott, Kim Edelstein

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of clinical and experimental neuropsychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07558473 (Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07558473 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors

TypeinterventionalSponsorHugo W. Moser Research Institute at Kennedy Krieger, Inc.Ran2026 to 2033Enrolled300ConditionsBrain Tumor, PediatricArmsOnline computerized cognitive training intervention focused on processing speed.
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lisa M JacolaDepartment of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Rachel K PetersonCenter for Neuropsychological and Psychological Assessment, Kennedy Krieger Institute, Baltimore, MD, USA.
Kaitlin A Oswald-McCloskeyDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Angela SekelyDepartment of Supportive Care, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Donald J MabbottNeurosciences and Mental Health Program, Research Institute, The Hospital for Sick Children, Toronto, ON, Canada.
Kim EdelsteinDepartment of Supportive Care, Princess Margaret Cancer Centre, Toronto, ON, Canada.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Markos Leggas · 1985 to 2026
$166.9M
PAARK4Kids-Pharmacogenomics of Anticancer Agents Research in ChildrenU01GM092666 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RELLING, MARY V · 2010 to 2014
$8.9M
NCI NIH HHS P30 CA021765NIGMS NIH HHS U01 GM092666
6 · The paper itself

Abstract

Population-based incidence rates of childhood and adolescent cancers have increased over the past several decades, and the overall survival rate for childhood cancer exceeds 85% due to advances in treatment. There is a substantial burden of late effects in this growing and youthful survivorship population. In particular, neuropsychological late effects are common and life-altering sequelae of childhood cancer that adversely impact educational attainment, vocational attainment, and social integration. In this review article, we summarize the extant literature to describe neuropsychological late effects in survivors of childhood cancer, including underlying brain mechanisms and contributing individual, clinical, and socioenvironmental risk factors. We review existing guidelines for survivorship care and strategies for implementation of these guidelines via neuropsychological screening that are informed by developmental considerations. We end by identifying future directions for the field.

Indexed as

Cancer SurvivorsNeoplasmsAdolescentAdultChildHumansNeuropsychological TestsChildhood cancerneuropsychological guidelinesneuropsychological outcomesneuropsychological screeningsurvivorship

Identifiers

PMID40635330
PMCPMC12392990

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.